DIAMICRON 60MG, comprimé sécable à libération modifiée, Placebo S05762, METFORMIN, Forxiga 10 mg film-coated tablets
S005201-175
Phase 3 small_molecule active
Quick answer
DIAMICRON 60MG, comprimé sécable à libération modifiée, Placebo S05762, METFORMIN, Forxiga 10 mg film-coated tablets for Type 2 Diabetes inadequately controlled with dapagliflozin with or without metformin is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Type 2 Diabetes inadequately controlled with dapagliflozin with or without metformin
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active